Maxim Kebenko
Overview
Explore the profile of Maxim Kebenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vorwerk J, Liu L, Stadler T, Frank D, Ahmed H, Patnana P, et al.
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857691
: GFI1-36N represents a single-nucleotide polymorphism (SNP) of the zinc finger protein Growth Factor Independence 1 (GFI1), in which the amino acid serine (S) is replaced by asparagine (N). The...
2.
Preyer L, Vettorazzi E, Fiedler W, Rohde H, Stemler J, Gonner S, et al.
Front Oncol
. 2024 Nov;
14:1429221.
PMID: 39484033
Introduction: Our monocentric and retrospective study aimed to investigate the clinical effectivity of HEPA filters in combination with the antifungal drug prophylaxis in patients with AML undergoing intensive chemotherapy and...
3.
Fahnrich A, Gasimova Z, Maluje Y, Ott F, Sievert H, Fliedner S, et al.
Front Oncol
. 2024 Oct;
14:1445427.
PMID: 39391235
Tenosynovial giant cell tumor (TGCT) is a rare type of tumor that originates from the synovium of joints and tendon sheaths. It is characterized by recurring genetic abnormalities, often involving...
4.
Loser A, Fabian A, Ruhle A, Thieme A, Baehr A, Kasmann L, et al.
Strahlenther Onkol
. 2024 Feb;
200(7):583-594.
PMID: 38381142
Background And Objective: Data on enteral tube feeding in head and neck cancer (HNC) patients undergoing chemoradiotherapy vary considerably between German institutions. This survey aims to investigate the management of...
5.
Klement P, Fiedler W, Gabdoulline R, Dallmann L, Wienecke C, Schiller J, et al.
Ann Hematol
. 2022 Dec;
102(2):323-328.
PMID: 36576532
Relapse in patients with acute myeloid leukemia (AML) is common and is associated with a dismal prognosis. Treatment options are limited and the understanding of molecular response patterns is still...
6.
Grunwald V, Pink D, Egerer G, Schalk E, Augustin M, Deinzer C, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358652
This non-interventional, prospective phase IV trial evaluated trabectedin in patients with soft tissue sarcoma (STS) in real-life clinical practice across Germany. The primary endpoints were progression-free survival (PFS) rates at...
7.
Pink D, Andreou D, Bauer S, Brodowicz T, Kasper B, Reichardt P, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33799576
We aimed to evaluate the efficacy and toxicity of paclitaxel combined with pazopanib in advanced angiosarcoma (AS). The primary end point was progression-free survival (PFS) rate at six months (PFSR6)....
8.
Fiedler W, Chromik J, Amberg S, Kebenko M, Thol F, Schlipfenbacher V, et al.
Br J Haematol
. 2020 Jun;
190(3):e169-e173.
PMID: 32515072
No abstract available.
9.
Krauter J, Fiedler W, Schlenk R, Paschka P, Thol F, Lubbert M, et al.
Br J Haematol
. 2018 Nov;
183(2):235-241.
PMID: 30378121
This open-label, multicentre phase I/II study determined the maximum tolerated dose (MTD), safety and efficacy of clofarabine administered with cytarabine and idarubicin in newly diagnosed acute myeloid leukaemia (AML) patients...
10.
Kebenko M, Goebeler M, Wolf M, Hasenburg A, Seggewiss-Bernhardt R, Ritter B, et al.
Oncoimmunology
. 2018 Sep;
7(8):e1450710.
PMID: 30221040
We assessed the tolerability and antitumor activity of solitomab, a bispecific T-cell engager (BiTE®) antibody construct targeting epithelial cell adhesion molecule (EpCAM). Patients with relapsed/refractory solid tumors not amenable to...